mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.1 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.1 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |